share_log

Rivian Automotive | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(4.7%)

SEC announcement ·  May 10 12:14
Summary by Moomoo AI
On April 30, 2024, T. Rowe Price Associates, Inc. filed an amendment to Schedule 13G with the SEC, indicating a change in its holdings of Rivian Automotive Inc-A common stock. The filing, which is an update to the investment firm's ownership stake, shows that T. Rowe Price now beneficially owns 46,062,732 shares, representing 4.7% of the class. This marks a decrease as T. Rowe Price is no longer the beneficial owner of more than five percent of Rivian's common stock. The filing was made in accordance with Rule 13d-1(b) under the Securities Exchange Act of 1934. T. Rowe Price, an investment adviser registered under the Investment Advisers Act of 1940, has declared that the securities were acquired in the ordinary course of business and...Show More
On April 30, 2024, T. Rowe Price Associates, Inc. filed an amendment to Schedule 13G with the SEC, indicating a change in its holdings of Rivian Automotive Inc-A common stock. The filing, which is an update to the investment firm's ownership stake, shows that T. Rowe Price now beneficially owns 46,062,732 shares, representing 4.7% of the class. This marks a decrease as T. Rowe Price is no longer the beneficial owner of more than five percent of Rivian's common stock. The filing was made in accordance with Rule 13d-1(b) under the Securities Exchange Act of 1934. T. Rowe Price, an investment adviser registered under the Investment Advisers Act of 1940, has declared that the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Rivian Automotive. The filing also states that any discretionary authority delegated to T. Rowe Price may be revoked at any time by its clients, and no single client owns more than 5% of the class of securities advised by T. Rowe Price.

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more